Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Benhealth bispecific antibody injection
- Development stage
- Preclinical
- Lead developer
- Benhealth Biopharmaceutical
- Modality
- Bispecific Antibodies → Multispecific Antibodies → Engineered Antibody Formats → Antibody-Based Therapeutics
- Administration
- Injection
01
Overview
Benhealth's bispecific antibody injection is an experimental therapeutic candidate developed by Benhealth (Benhealth Biopharmaceutical) for the treatment of advanced solid tumors, specifically pancreatic cancer with liver metastases. The drug is part of Benhealth's technology platform which focuses on combining bispecific antibodies with immune effector cells, such as T-cells or NK-cells, to enhance anti-tumor activity. Although the specific molecular targets of this antibody have not been publicly disclosed, it has been highlighted in patient case studies demonstrating clinical application in late-stage pancreatic cancer patients. The therapy is administered via injection and is intended to facilitate targeted immune-mediated destruction of cancer cells.
- Other names
- 双抗注射液Bispecific Antibody Injection
02
Targets
MAGEA8 (Melanoma-associated antigen 8)CD3 (T-cell surface glycoprotein CD3)FCGR3B (Fc gamma receptor III)
Beyond the preview
Go deeper on Benhealth bispecific antibody injection.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Benhealth bispecific antibody injection.